Search

Evotec AG

Gesloten

SectorFinanciën

3.42 -3.39

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.4

Max

3.48

Belangrijke statistieken

By Trading Economics

Inkomsten

-137M

-122M

Verkoop

-97M

157M

EPS

0.082

Winstmarge

-77.843

Werknemers

4,526

EBITDA

-80M

-32M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+69.86% upside

Dividenden

By Acuity

Volgende Winsten

5 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-300M

650M

Vorige openingsprijs

6.81

Vorige sluitingsprijs

3.42

Nieuwssentiment

By Acuity

41%

59%

126 / 437 Rangschikking in Finance

Evotec AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 aug 2026, 23:52 UTC

News

Boeing Co secures over $711 million in U.S. defense contract modifications, boosting investor sentiment. Shares are higher in after-market trading.

14 aug 2026, 23:51 UTC

News

PayPal is in advanced talks for a potential sale to Stripe and Advent, following a proposal of $60.50 per share. Shares are higher in after-market trading.

14 aug 2026, 23:51 UTC

News

Tyson Foods will close its beef facility in Joslin, Illinois, resulting in about 2,500 job losses, as shares trade lower in after-market hours.

14 aug 2026, 23:46 UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from a securities fraud lawsuit related to its RP1 application.

14 aug 2026, 23:46 UTC

News

Delek US Holdings shares rose in after-market hours following Delek Logistics Partners' $230 million public offering of common units at $50.00 each.

14 aug 2026, 23:46 UTC

News

Patterson-UTI Energy reported 98 drilling rigs operating in July. Shares rose in after-market trading, reflecting strong activity and nearing the upper end of their one-month range.

14 aug 2026, 23:46 UTC

News

Kraft Heinz Co shares are lower in after-market trading following a $100 million marketing announcement and concerns over July's U.S. retail sales drop.

14 aug 2026, 23:41 UTC

News

Elliott Investment Management increased its stake in Hewlett Packard Enterprise by 17.7%, contributing to higher after-market trading for the shares.

14 aug 2026, 23:36 UTC

News

Dynatrace shares are higher in after-hours trading following Starboard Value's SEC filing disclosing an 8.9 million share stake.

14 aug 2026, 23:31 UTC

News

Texas Pacific Land Corp shares are higher in after-market hours, with a current price of $358.89 and a market capitalization of $24.75 billion.

14 aug 2026, 23:31 UTC

News

Jana Partners disclosed a new stake in Rapid7 Inc, acquiring over 6.7 million shares. Shares advanced during after-market hours following the announcement.

14 aug 2026, 23:21 UTC

News

MongoDB Inc. showcases AI focus with new Atlas Managed MCP Server tools and Voyage AI features. Shares are little changed in after-market trading.

14 aug 2026, 23:21 UTC

News

Constellation Brands shares are trading lower after Berkshire Hathaway dissolved its stake, contributing to negative sentiment amid broader weakness in the Distillers & Vintners sector.

14 aug 2026, 23:21 UTC

News

Embecta Corp shares are lower in after-market hours amid negative sentiment from two class action lawsuits alleging securities fraud and disappointing second-quarter guidance.

14 aug 2026, 23:11 UTC

News

Lattice Semiconductor granted over 414,000 RSUs and PRSUs to new employees as part of its equity incentive plan. Shares are trading roughly flat in after-market hours.

14 aug 2026, 23:11 UTC

News

Lone Pine Capital LLC reduced its stake in McKesson Corp by 85.3% to 57,851 shares, contributing to the stock's decline in after-market trading.

14 aug 2026, 23:06 UTC

News

Berkshire Hathaway raised its stake in Delta Air Lines by 44%, now holding 57.3 million shares. Shares are trading higher in after-market hours.

14 aug 2026, 23:06 UTC

News

Mastercard proposes a plan for Brazilian payment processors to absorb R$2.5 billion in losses from Banco Master’s collapse, as shares decline in after-market trading.

14 aug 2026, 23:06 UTC

News

Viking Global Investors has cut its stake in Walt Disney by a significant amount, while ValueAct Holdings has fully exited its position. Shares are lower in after-market trading.

14 aug 2026, 23:02 UTC

News

Target shares lower in after-market trading despite Telsey Advisory Group's Outperform rating and raised price target to $170. Broader market weakness weighs on performance.

14 aug 2026, 23:01 UTC

News

ServiceNow Inc shares fell in after-market trading to about $124.03 amid broader market concerns following a drop in U.S. retail sales.

14 aug 2026, 23:01 UTC

News

Berkshire Hathaway's Form 13F filing revealed a new position in DR Horton, boosting investor interest and driving shares higher in after-hours trading.

14 aug 2026, 23:01 UTC

News

Warner Bros Discovery Inc. shares declined in after-market hours amid regulatory scrutiny over its merger with Paramount Skydance Corp, facing opposition from state attorneys general.

14 aug 2026, 23:01 UTC

News
Social Media

Genco Shipping & Trading shares lower in after-market trading following Diana Shipping's withdrawal of its acquisition offer, citing unrealistic demands from Genco's Board.

14 aug 2026, 23:01 UTC

News
Social Media

Berkshire Hathaway increased its stake in Macy's to 7.3 million shares, contributing to positive sentiment as shares advanced in after-market trading.

14 aug 2026, 23:01 UTC

News

Baker Hughes Co shares are lower in after-market hours amid rising oil and gas rig counts and concerns over a decline in U.S. retail sales.

14 aug 2026, 23:01 UTC

News

MSCI Inc. shares are higher in after-market trading, reflecting a cumulative gain since Friday's close and a market capitalization of $41.38 billion.

14 aug 2026, 23:01 UTC

News

Berkshire Hathaway increased its stake in New York Times Co. by 3.7%, contributing to a modest rise in after-market trading.

14 aug 2026, 23:01 UTC

News

NIO shares rose during after-market hours to about $4.50, as options sentiment showed mixed signals ahead of the upcoming earnings report.

14 aug 2026, 23:01 UTC

News

Realty Income Corp closed a $1.0 billion private offering of convertible senior notes, with proceeds for share repurchases and debt repayment. Shares are higher in after-market trading.

Peer Vergelijking

Prijswijziging

Evotec AG Prognose

Koersdoel

By TipRanks

69.86% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 6.03 EUR  69.86%

Hoogste 10 EUR

Laagste 3.6 EUR

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Evotec AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Sentiment

By Acuity

126 / 437 Rangschikking in Financiën

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Evotec AG

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer; and Inserm, the French National Institute of Health and Medical Research, Lille University Hospital, and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases, as well as collaboration with CHDI Foundation, Inc.; and a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic, as well as research collaboration with Pfizer for metabolic and infectious diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
help-icon Live chat